ChromaDex Corporation (CDXC) financial statements (2020 and earlier)

Company profile

Business Address 10900 WILSHIRE BLVD
LOS ANGELES, CA 90024
State of Incorp. DE
Fiscal Year End December 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1923452642
Cash and cash equivalents1923452642
Receivables2556221
Inventory, net of allowances, customer advances and progress billings12868842
Inventory12868842
Other undisclosed current assets1110000
Total current assets:3437571617106
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment4433211
Long-term investments and receivables   0  2
Long-term investments   0  2
Intangible assets, net (including goodwill)1220000
Intangible assets, net (excluding goodwill)1220000
Regulated entity, other noncurrent assets  0  0 
Deposits noncurrent assets 000000
Other noncurrent assets10   0 
Prepaid expense and other noncurrent assets2
Other undisclosed noncurrent assets  1  (1)(2)
Total noncurrent assets:7664223
TOTAL ASSETS:4042632019129
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities141478842
Accounts payable101046631
Accrued liabilities4442111
Employee-related liabilities  0    
Interest and dividends payable    00 
Debt1000000
Due to related parties  0    
Deferred revenue and credits000000
Other undisclosed current liabilities0000200
Total current liabilities:1514891053
Noncurrent Liabilities
Long-term debt and lease obligation1000420
Long-term debt, excluding current maturities    32 
Finance lease, liability0
Capital lease obligations000000
Operating lease, liability1
Liabilities, other than long-term debt4000(0)(0)0
Deferred revenue and credits000(0)(0)0
Deferred revenue4
Other undisclosed noncurrent liabilities 00000 
Total noncurrent liabilities:5111430
Total liabilities:20159101383
Stockholders' equity
Stockholders' equity attributable to parent, including:20275410546
Common stock0000000
Additional paid in capital14211711055474340
Accumulated deficit(122)(90)(57)(45)(42)(40)(34)
Other undisclosed stockholders' equity attributable to parent     0 
Total stockholders' equity:20275410546
TOTAL LIABILITIES AND EQUITY:4042632019129

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues46322127221510
Revenue, net32127221510
Revenue from related parties7 
Cost of revenue(21)(16)(11)(15)(14)(10)(7)
Gross profit:26161012853
Operating expenses(57)(49)(27)(14)(11)(11)(8)
Operating loss:(31)(33)(16)(2)(2)(5)(4)
Nonoperating expense(1)(0)(0)(1)(1)(0)(0)
Investment income, nonoperating  50002
Interest and debt expense(1)(0)(0)(0)(1)(0)(0)
Loss from continuing operations before equity method investments, income taxes:(33)(33)(17)(3)(3)(6)(4)
Other undisclosed income from continuing operations before income taxes  001  
Loss from continuing operations before income taxes:(33)(33)(17)(3)(3)(6)(4)
Income tax expense    (0)  
Loss from continuing operations:(33)(33)(17)(3)(3)(6)(4)
Income from discontinued operations  5    
Net loss:(33)(33)(11)(3)(3)(6)(4)
Other undisclosed net income attributable to parent10   00
Net loss available to common stockholders, diluted:(32)(33)(11)(3)(3)(5)(4)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(33)(33)(11)(3)(3)(6)(4)
Comprehensive loss, net of tax, attributable to parent:(33)(33)(11)(3)(3)(6)(4)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: